Ross C. Larue and Amit Sharma are both researchers based at the University of Ohio. Along with their colleagues, they discovered a way in which peptides ‘trick’ the SARS-CoV-2 Virus that it latched onto a host cell, thereby deactivating it. Their findings were published in the Bioconjugate Chemistry journal.
The researchers state that “Spike proteins are essential for viral replication as they mediate viral entry into the host cell.” (1)
The Spike glycoproteins bind the host angiotensin-converting enzyme 2 (ACE2) receptor through their receptor binding domains (RBDs), specifically.
Through an extensive research and study process, the researchers found two specific peptides which resembled the spiral-like tail on an ACE2 receptor. The Spike glycoproteins on the SARS-CoV-2 virus attach to these peptides.
Promising results came from the study as the viral particles were deactivated once they latched to the peptides, reducing the possibility of viral replication.
The researchers are in the process of patenting their findings, meaning their product could be hitting the shelves soon.
The monumental aspect of this study is that the researchers have found an intervention that does not take place within our bodies.
Although there are talks of one of the products being a peptide-based nasal spray (which would combat the virus upon entry), the idea of an aerosol spray that inactivates the virus when applied to surfaces is especially intriguing.
As mainstream media pushes the agenda that receiving a COVID-19 vaccination is the only way to intervene with the SARS-CoV-2 virus, it is no wonder that this discovery has yet to breach major headlines.
At The Wellness Way, we recommend fighting viruses by taking care of yourself and maintaining a healthy immune system. By investing in preventative care for yourself and your body, pharmacological interventions will no longer be the only option for being healthy.
Consult with one of our knowledgeable doctors today, and avoid the worrisome process of participating in experimental interventions with unknown consequences.
Register for our newsletter.